- Home
- CDTX vs HEPS Comparison
CDTX vs HEPS Comparison
Compare CDTX & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDTX
- HEPS
- Stock Information
- Founded
- CDTX 2012
- HEPS 2000
- Country
- CDTX United States
- HEPS Turkey
- Employees
- CDTX N/A
- HEPS N/A
- Industry
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- HEPS Catalog/Specialty Distribution
- Sector
- CDTX Health Care
- HEPS Consumer Discretionary
- Exchange
- CDTX Nasdaq
- HEPS Nasdaq
- Market Cap
- CDTX 980.1M
- HEPS 818.3M
- IPO Year
- CDTX 2015
- HEPS 2021
- Fundamental
- Price
- CDTX $63.31
- HEPS $2.69
- Analyst Decision
- CDTX Strong Buy
- HEPS
- Analyst Count
- CDTX 11
- HEPS 0
- Target Price
- CDTX $52.11
- HEPS N/A
- AVG Volume (30 Days)
- CDTX 659.9K
- HEPS 681.1K
- Earning Date
- CDTX 08-07-2025
- HEPS 07-30-2025
- Dividend Yield
- CDTX N/A
- HEPS N/A
- EPS Growth
- CDTX N/A
- HEPS N/A
- EPS
- CDTX N/A
- HEPS N/A
- Revenue
- CDTX $302,000.00
- HEPS $1,477,672,859.00
- Revenue This Year
- CDTX N/A
- HEPS $33.20
- Revenue Next Year
- CDTX N/A
- HEPS $25.66
- P/E Ratio
- CDTX N/A
- HEPS N/A
- Revenue Growth
- CDTX N/A
- HEPS 49.45
- 52 Week Low
- CDTX $10.14
- HEPS $2.11
- 52 Week High
- CDTX $66.95
- HEPS $4.05
- Technical
- Relative Strength Index (RSI)
- CDTX 70.66
- HEPS 54.32
- Support Level
- CDTX $60.71
- HEPS $2.42
- Resistance Level
- CDTX $66.95
- HEPS $2.56
- Average True Range (ATR)
- CDTX 4.25
- HEPS 0.11
- MACD
- CDTX -0.39
- HEPS -0.00
- Stochastic Oscillator
- CDTX 79.25
- HEPS 72.19
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.